These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 27206913)
21. Coronary bioresorbable vascular scaffolds: requiescant in pace? Alfonso F; Cuesta J; Rivero F Rev Esp Cardiol (Engl Ed); 2021 Jul; 74(7):569-572. PubMed ID: 33622635 [No Abstract] [Full Text] [Related]
22. Coronary artery aneurysms formation within Everolimus-eluting stents and bioresorbable vascular scaffolds. Lee WC; Chung WJ; Fang HY; Wu CJ Int J Cardiol; 2016 Mar; 206():58-60. PubMed ID: 26774833 [No Abstract] [Full Text] [Related]
23. Treading the risky ground of coronary bifurcation lesion revascularization, the "biodegradable strategy" may represent the lifeline. Piraino D; Buccheri D; Andolina G Int J Cardiol; 2016 Oct; 221():577-80. PubMed ID: 27420582 [No Abstract] [Full Text] [Related]
24. [Bioresorbable scaffolds in the treatment of coronary artery disease. Expert consensus statement of the Association of Cardiovascular Interventions of the Polish Cardiac Society (ACVI PCS)]. Reczuch K; Milewski K; Wąsek W; Rzeszutko Ł; Wojakowski W; Hawranek M; Włodarczak A; Pawłowski T; Kochman J; Dobrzycki S; Grygier M; Ochała A; Wójcik J; Lesiak M; Dudek D; Legutko J Kardiol Pol; 2017; 75(8):817-835. PubMed ID: 28819961 [TBL] [Abstract][Full Text] [Related]
25. What about the risk of thrombosis with bioresorbable scaffolds? Capodanno D; Joner M; Zimarino M EuroIntervention; 2015; 11 Suppl V():V181-4. PubMed ID: 25983162 [TBL] [Abstract][Full Text] [Related]
26. Initial experience of percutaneous coronary intervention in bifurcations with bioresorbable vascular scaffolds using different techniques--insights from optical coherence tomography. Attizzani GF; Ohno Y; Capranzano P; La Manna A; Francaviglia B; Grasso C; Sgroi C; Tamburino C; Longo G; Fujino Y; Capodanno D; Tamburino C Int J Cardiol; 2013 Dec; 170(2):e33-5. PubMed ID: 24210418 [No Abstract] [Full Text] [Related]
31. [Bioresorbable Vascular Scaffold: A Focused Review on Development and Preclinical Studies]. Ke L; Huang Y; Liu L; Duan X; Feng X; Wang C Zhongguo Yi Liao Qi Xie Za Zhi; 2018 Feb; 42(2):115-118. PubMed ID: 29845812 [TBL] [Abstract][Full Text] [Related]
32. Subacute recoil in bioresorbable vascular scaffold in a complex coronary lesion: A lesson from daily clinical practice. Centola M; Lucreziotti S; Salerno-Uriarte D; Tresoldi S; Cannone G; Sponzilli C; Carugo S Int J Cardiol; 2016 Jan; 203():995-6. PubMed ID: 26625328 [No Abstract] [Full Text] [Related]
33. Hybrid ABSORB bioresorbable vascular scaffold and drug eluting stent or hybrid BVS-DES percutaneous coronary intervention: Method and rationale for hybrid overlapping PCI. Yew KL Int J Cardiol; 2015; 186():74-6. PubMed ID: 25814348 [No Abstract] [Full Text] [Related]
34. When and how to use BRS in bifurcations? Stankovic G; Lassen JF EuroIntervention; 2015; 11 Suppl V():V185-7. PubMed ID: 25983163 [TBL] [Abstract][Full Text] [Related]
35. Current perspectives on the role of bioresorbable scaffolds in the management of coronary artery disease. Dziewierz A; Dudek D Kardiol Pol; 2018; 76(7):1043-1054. PubMed ID: 30251247 [TBL] [Abstract][Full Text] [Related]
36. Comparison of everolimus- and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds. Puricel S; Arroyo D; Corpataux N; Baeriswyl G; Lehmann S; Kallinikou Z; Muller O; Allard L; Stauffer JC; Togni M; Goy JJ; Cook S J Am Coll Cardiol; 2015 Mar; 65(8):791-801. PubMed ID: 25720622 [TBL] [Abstract][Full Text] [Related]
37. Bioresorbable scaffolds: a new paradigm in percutaneous coronary intervention. Tenekecioglu E; Farooq V; Bourantas CV; Silva RC; Onuma Y; Yılmaz M; Serruys PW BMC Cardiovasc Disord; 2016 Feb; 16():38. PubMed ID: 26868826 [TBL] [Abstract][Full Text] [Related]
38. Complete healing of a bifurcation lesion treated with the implantation of 2 bioresorbable vascular scaffolds with the T and small protrusion technique. Łanocha M; Lesiak M Kardiol Pol; 2019 Apr; 77(4):488-489. PubMed ID: 31025651 [No Abstract] [Full Text] [Related]
39. Impact of overlapping on 1-year clinical outcomes in patients undergoing everolimus-eluting bioresorbable scaffolds implantation in routine clinical practice: Insights from the European multicenter GHOST-EU registry. Ortega-Paz L; Capodanno D; Giacchi G; Gori T; Nef H; Latib A; Caramanno G; Di Mario C; Naber C; Lesiak M; Capranzano P; Wiebe J; Mehilli J; Araszkiewicz A; Pyxaras S; Mattesini A; Geraci S; Naganuma T; Colombo A; Münzel T; Sabaté M; Tamburino C; Brugaletta S Catheter Cardiovasc Interv; 2017 Apr; 89(5):812-818. PubMed ID: 27515568 [TBL] [Abstract][Full Text] [Related]
40. Complex bifurcation lesions: Randomized comparison of a fully bioresorbable modified t stenting strategy versus bifurcation reconstruction with a dedicated self-expanding stent in combination with bioresorbable scaffolds, an OCT study: Rationale and design of the COBRA II trial. Bennett J; Adriaenssens T; Desmet W; Dubois C Catheter Cardiovasc Interv; 2016 Nov; 88(6):843-853. PubMed ID: 27184586 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]